Search results for "Primary prevention"
New guideline recommends low-dose aspirin for many fewer patients
Changes to the American College of Cardiology/American Heart Association guideline include no longer routinely giving low-dose aspirin for primary prevention to adults older than age 70 years or to younger patients who are not at high risk.
https://immattersacp.org/weekly/archives/2019/03/26/1.htm
26 Mar 2019
MKSAP quiz: Evaluation during a routine examination
A 59-year-old man is evaluated during a routine examination. He feels well and has no symptoms. Medical history is significant for hypertension. On physical examination, the patient is afebrile, blood pressure is 122/74 mm Hg, and pulse rate is 76/min. Cardiac examination is unremarkable. What is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2019/12/17/3.htm
17 Dec 2019
MKSAP Quiz: Evaluation for a carotid bruit
A 67-year-old man is evaluated for a carotid bruit detected on routine medical examination. He reports no history of previous focal neurologic symptoms or visual loss. He has type 2 diabetes mellitus and hyperlipidemia treated with metformin, moderate-intensity pravastatin, and aspirin. Following a physical exam, neurological exam, and lab results, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2019/11/12/3.htm
12 Nov 2019
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/22/1.htm
22 Nov 2016
Aspirin associated with fewer CV events, more major bleeding in healthy patients, review finds
When weighing the risks and benefits of aspirin for primary cardiovascular (CV) prevention in individual patients, clinicians must also consider other interventions that may lower risk, an accompanying editorial said.
https://immattersacp.org/weekly/archives/2019/01/29/1.htm
29 Jan 2019
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
Low-dose aspirin's effects on survival may come with caveats
A trial was stopped early after researchers determined that continued aspirin use appeared to yield no benefit.
https://immattersacp.org/weekly/archives/2018/09/18/2.htm
18 Sep 2018
Updated guideline on cholesterol management focuses on detailed risk assessment
The guideline from the American College of Cardiology/American Heart Association recommends that physicians talk to patients about risk-enhancing factors that can help provide a more personalized risk assessment, in addition to such traditional risk factors as smoking and high blood pressure.
https://immattersacp.org/weekly/archives/2018/11/20/2.htm
20 Nov 2018
Folic acid supplementation may help prevent first stroke in high-risk patients with hypertension
Among patients with low platelet count and high total homocysteine levels, receiving folic acid reduced the risk of first stroke by 73%, whereas there was no significant effect of folic acid among low-risk patients.
https://immattersacp.org/weekly/archives/2018/05/08/2.htm
8 May 2018
New cholesterol guideline focuses on statin intensity, not LDL
A new cholesterol guideline focuses on the intensity of statin therapy, the 10-year risk or lifetime risk, and the balancing of those benefits with the risks and side effects of the medicine. Also, the therapeutic response should be considered when managing hyperlipidemia.
https://immattersacp.org/archives/2014/06/cholesterol.htm
1 Jun 2014